Aarti Pharmalabs Ltd.

factsheet Factsheet
  • Value Research Rating market-capitalisation-info
    UnratedSee Why?
  • Market Capitalisation market-capitalisation-info ₹4,249 Cr
  • Price to Earnings Ratio price-to-earning 21.85
  • 12 Month Earnings monthly-earning ₹195 Cr

Aarti Pharmalabs Ltd. Share Price

₹468.60

As on 16-Apr-2024 IST

up-down-arrow8.501.85%

  • Prev Close info

    460.10

  • Day's Openinfo

    457.35

  • Today's Highinfo

    471.00

  • Today's Lowinfo

    456.35

  • Today's Volumeinfo

    1,85,740

  • 52 Week rangeinfo

    ₹320.30 - 566.95

Please wait...

Aarti Pharmalabs Ltd. Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Aarti Pharmalabs
-7.11 5.50 -10.70 46.90 -- -- --
S&P BSE CDG&S
10.13 6.56 7.21 57.12 24.87 18.45 --
S&P BSE Small Cap
6.44 8.12 1.96 61.37 29.74 24.62 19.73
As on 16-Apr-2024
The underlying data is unavailable.

Valuation Score

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Aarti Pharmalabs Ltd. Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart of Aarti Pharmalabs Ltd.

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        News & Analysis of Aarti Pharmalabs Ltd.

        No Review & Analysis are available.

        Other details of Aarti Pharmalabs Ltd.

        Incorporated

        2019

        Chairman

        Rashesh Chandrakant Gogri

        Managing Director

        Narendra Jagannath Salvi

        Headquarters

        Vapi, Gujarat

        FAQs for Aarti Pharmalabs Ltd.

        The total asset value of Aarti Pharmalabs Ltd. stood at ₹ 2,313 Cr as on 31-Dec-23

        The share price of Aarti Pharmalabs Ltd. is ₹468.60 (NSE) and ₹468.90 (BSE) as of 16-Apr-2024 IST. Aarti Pharmalabs Ltd. has given a return of 46.9% in the last 1 years.

        Aarti Pharmalabs Ltd. has a market capitalisation of ₹ 4,249 Cr as on 16-Apr-2024. As per Value Research classification, it is a Small Cap company.

        The P/B ratio of Aarti Pharmalabs Ltd. is 2.48 times as on 16-Apr-2024, a -0.44% premium to its peers’ median range of 4.46 times.

        The P/E ratio of Aarti Pharmalabs Ltd. is 21.85 times as on 16-Apr-2024, a -0.44% premium to its peers’ median range of 39.06 times.

        Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
        Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
        Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
        Step 4. Search for the Aarti Pharmalabs Ltd. and enter the required number of quantities and click on buy to purchase the shares of Aarti Pharmalabs Ltd..

        Aarti Pharmalabs Limited manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, new chemical entities, and xanthine derivatives in India. The company was formerly known as Aarti Organics Limited. Aarti Pharmalabs Limited was incorporated in 2019 and is based in Mumbai, India.

        The prominent promoters of Aarti Pharmalabs Ltd. are

        Name of promoters Holding percentage

        Rashesh Chandrakant Gogri

        4.23%

        Anushakti Enterprise Private Limited

        3.28%

        LABDHI BUSINESS TRUST (Saswat Trusteeship Private Limited)

        3.14%

        Renil Rajendra Gogri

        3.08%
        Click here to see the full list

        The chairman of the company is Rashesh Chandrakant Gogri, and the managing director is Narendra Jagannath Salvi.

        The promoters of Aarti Pharmalabs Ltd. have pledged 0% of the total equity as on Mar-24.

        Some of the close peers are:

        Company Market Cap(₹ Cr)
        11,612
        6,545
        4,486
        3,168
        Aarti Pharmalabs Ltd. Ratios
        Return on equity(%)
        12.1
        Return on capital employed(%)
        --
        Debt-to-equity ratio
        0
        Dividend yield(%)
        0.43

        Yes, TTM profit after tax of Aarti Pharmalabs Ltd. was ₹195 Cr.

        Edit peer-selector-edit
        Please wait...
        Please wait...
        Please wait...
        Please wait...

        Key Facts

        • Market cap market-cap-information ₹4,249.45 Cr
        • Revenue (TTM)revenue-information ₹1,831.91 Cr
        • Earnings (TTM) earning-information ₹194.52 Cr
        • Cash date-information ₹69.77 Cr
        • Total Debt info ₹214.34 Cr
        • Promoters' ownership promoters_ownership 46.46%
        • Liquidity liquidity High
        • 52 Week range week-range ₹320.30 - 566.95
        • Face value face-value ₹5.00
        • Shares outstanding share-outstanding 9,06,26,008

        About The Company

        • Incorporated 2019
        • Chairman Rashesh Chandrakant Gogri
        • Managing Director Narendra Jagannath Salvi
        • Listing key-listing NSE: AARTIPHARM, BSE: 543748
        • Country India
        • Headquarters headquarters Vapi, Gujarat
        • Website website www.aartipharmalabs.com
        • Business

          Aarti Pharmalabs Limited manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, new chemical entities, and xanthine derivatives in India. The company was formerly known as Aarti Organics Limited. Aarti Pharmalabs...  Limited was incorporated in 2019 and is based in Mumbai, India.  Read more